Local therapy with IL2 and human lymphokine-activated killer (LAK) cells also significantly reduced the growth of tumors in a nude mouse model of human squamous-cell carcinoma of the head and neck [92]. The gene discussed is IL2; the disease is squamous cell carcinoma.